Other news
LinkedIn post ESRR2024
š¢ Important update on EU #GMP Annex 1 at #ESRR2024! The revised EU GMP Annex 1, effecti...
RTM receives marketing authorisation for Fludeoxyglucose (18F)
We are happy to announce that RTM has received marketing authorization for 18F-FDG of 17 July 2018....
ABX has received marketing authorisation for the radiotracer RadeluminĀ® in Germany
ABX has received marketing authorisation for the radiotracer RadeluminĀ® in Germany! This marks the 8...
1st production QuiremSpheres
On May 21st, the first patient dosis of QuiremSpheres was processed at RTM and then shipped to the s...
Interested in a collaboration?
Contact us to discuss the possibilities.